Nimodipine
SIGMA/N149
Synonym: 1,4-
CAS Number: 66085-59-4
Empirical Formula (Hill Notation): C21H26N2O7
Molecular Weight: 418.44
EC Number: 266-127-0
MDL Number: MFCD00153848
Linear Formula: C21H26N2O7
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | off-white to yellow |
| form | powder |
| InChI | 1S/C21H26N2O7/c1-12(2)30- |
| InChI key | UIAGMCDKSXEBJQ-UHFFFAOYSA |
| originator | Bayer |
| Quality Level | 200 ![]() |
| SMILES string | COCCOC(=O)C1=C(C)NC(C)=C( |
| solubility | 45% (w/v) aq 2-hydroxypropyl-β-cyclode |
| H2O: insoluble | |
| methanol: 62.5 mg/mL |
| Application: | Nimodipine has been used: • as a L-type calcium channel (LTCC) inhibitor, to evaluate its neuroprotective activity in the vibrosections • as a standard, in the enantioseparation of chiral drugs by high performance liquid chromatography (HPLC) • in the pharmacological studies for the measurement of spine voltage escape |
| Biochem/physiol Actions: | Nimodipine enhances the survival of dopaminergic substantia nigra neurons. |
| Biochem/physiol Actions: | Nimodipine is a potent L-type Ca2+ channel antagonist. |
| Disclaimer: | Photosensitive |
| Features and Benefits: | This compound is featured on the Calcium Channels page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Features and Benefits: | This compound was developed by Bayer . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 100, 500 mg in poly bottle |
| Symbol | GHS07 |
| Signal word | Warning |
| Hazard statements | H302 |
| Precautionary statements | P264 - P270 - P301 + P312 - P501 |
| Hazard Codes | Xn |
| Risk Statements | 48/22 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 1 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| UNSPSC | 12352200 |


